Vaccine and Treatment Evaluation Units (VTEU)

NIH RePORTER · NIH · UM1 · $5,921,655 · view on reporter.nih.gov ↗

Abstract

ABSTRACT This supplement request is for a Phase 3, randomized, stratified, observer-blind, placebo- controlled study to evaluate the efficacy, safety and immunogenicity, of mRNA-1273 vaccine compared to placebo in adults 18 years of age and older who have no known history of SARS- CoV-2 infection but whose locations or circumstances put them at appreciable risk of acquiring COVID-19 and/or SARS-CoV-2 infection. This request also relates to other COVID 19 activities.

Key facts

NIH application ID
10200480
Project number
3UM1AI148575-01S2
Recipient
BAYLOR COLLEGE OF MEDICINE
Principal Investigator
HANA M EL SAHLY
Activity code
UM1
Funding institute
NIH
Fiscal year
2020
Award amount
$5,921,655
Award type
3
Project period
2020-07-13 → 2022-11-30